Centrus Energy (LEU) has been under pressure after its first quarter 2026 results, as a higher full year revenue outlook and growing low enriched uranium backlog met softer earnings, missed revenue expectations, sector weakness, and valuation questions.

The Q1 2026 report and sector weakness have gone hand in hand with sharp share price pressure. The stock is down 30.06% over 30 days and 40.63% year to date on a share price basis, even though the 5 year total shareholder return sits above 500%. Recent momentum has clearly faded after a very strong longer term run.

If you are looking beyond Centrus to other nuclear fuel and power plays, this could be a useful moment to scan a focused list of 88 nuclear energy infrastructure stocks

So with Centrus now trading well below recent highs, but still carrying questions about earnings quality, insider selling and sector sentiment, is the stock trading at a discount, or is the market already pricing in future growth?

Most Popular Narrative: 73.5% Undervalued

According to one widely followed narrative, Centrus Energy's fair value of $609.90 sits far above the last close at $161.78, putting a spotlight on how investors frame its role in the US nuclear fuel chain.

Centrus Energy is one of those rare companies whose importance becomes clearer the deeper you look into the machinery of U.S. law, national security, and nuclear policy. In a sector defined by scarcity, Centrus isn’t just another uranium name; it is the only U.S. company legally authorized to enrich uranium for the federal government, a distinction rooted directly in federal statute. Under 10 U.S.C. § 2538a, the U.S. government is prohibited from purchasing enriched uranium for defense purposes from any entity that is not a U.S.-owned, U.S.-operated, and NRC-licensed enricher. That legal filter leaves exactly one company standing, Centrus. And that’s before you even get to the fact that Centrus is also the only firm with an NRC license to produce HALEU, the fuel required for nearly every advanced reactor design the U.S. is trying to deploy.

The narrative from RetiredbutWorking leans heavily on one thing, exclusivity. It then layers in fuel mix, margin assumptions and a future earnings multiple that reflects this policy status. Curious what growth, profitability and discount rate sit behind that $609.90 figure? The full narrative breaks those inputs out in detail so you can judge them for yourself.

Result: Fair Value of $609.90 (UNDERVALUED)

However, you still need to weigh concentration risk around US policy decisions, along with the possibility that sector sentiment or contract timing keeps the stock under pressure.

Another View: Earnings Multiple Flags a Pricing Gap

While the user narrative and fair value estimate lean heavily toward undervaluation, the current P/E of 52.5x tells a different story. It is far above the US Oil and Gas industry at 13.8x, the peer average at 11.7x, and the fair ratio of 9.8x, which points to meaningful valuation risk if sentiment cools.

For investors, the question is simple: does the market sustain such a premium, or could a shift toward the fair ratio pressure the share price even if the long term story stays intact?

Next Steps

If you feel the story is divided between strong potential and real concerns, start by reviewing the data, sentiment and valuation checks. Then consider the 1 key reward and 5 important warning signs to weigh these factors.

Looking for more investment ideas?

If Centrus has your attention, do not stop there. A few minutes with a targeted screener can surface opportunities you might otherwise miss.

• Hunt for overlooked quality by checking the screener containing 22 high quality undiscovered gems that combine solid fundamentals with quieter market attention.
• Zero in on resilience and capital strength through the solid balance sheet and fundamentals stocks screener (46 results) to spot companies with room to handle shocks.
• Focus on stability first and see what stands out in the 64 resilient stocks with low risk scores that filters for stocks with lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.